France· FR:69054203
TENTIN 20 mg, comprimé
A dexamfetamine product containing sulfate de dexamfétamine, registered in France by MEDICE ARZNEIMITTEL PÜTTER (ALLEMAGNE). The same ATC class is registered in 14 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Dexamfetamine is registered in 14 of 19 countries.
Countries holding a registration under ATC N06BA02 (dexamfetamine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Dexamfetamine · ATC N06BA02
14 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dexamfetamine costs, country by country.
Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dexamfetamine · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$4.49
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SULFATE DE DEXAMFÉTAMINE
- Manufacturer
- MEDICE ARZNEIMITTEL PÜTTER (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- N06BA02
- ATC class
- Dexamfetamine
- Defined daily dose
- 15 mg, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400930294864plaquette(s) PVC polyéthylène PVDC aluminium de 28 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for dexamfetamine.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dexamfetamine · interactions on record
89 records
- 16 severe
- 73 moderate
Most severe, free to view
- FenfluramineA08AA02severe
- DexfenfluramineA08AA04severe
- SibutramineA08AA10severe
- ProcarbazineL01XB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dexamfetamine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenAttentin 20 mg TablettMedice Arzneimittel Pütter GmbH & Co. KG
- FinlandAttadexAbboxia AB
- United StatesDextroamphetamine SulfateWilshire Pharmaceuticals, Inc.
- NetherlandsAttenfarm 20 mg tablettenOrifarm Healthcare A/S
- NorwayAttentinMedice Arzneimittel Pütter GmbH & Co KG
- SwitzerlandAttentin
- PolandTentinMedice Arzneimittel Puetter GmbH & Co. KG
- United KingdomAmfexa 20mg tabletsMedice UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Philla
- Belgium · Adhesa, Attentin
- Germany · Attentin, Dexamfetamin Orifarm
- Denmark · Adhesa, Attentin
- Estonia · Tentin
- Spain · Tentin
- Finland · Adhesa 5 Mg Tabletti, Attadex
- United Kingdom (Northern Ireland) · Amfexa, Dexamfetamine Sulfate
- Iceland · Attentin, Dexamfetamine Taw Pharma (Ireland)
- Italy · Amfexa
- Luxembourg · Attentin
- Malta · Dexamfetamine Sulfate
- Netherlands · Adhesa, Attenfarm
- Norway · Attentin, Deksamfetamin Waymade B.V.
- Poland · Tentin
- Portugal · Tentin
- Sweden · Attentin, Dexamfetamin Sea Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/75d4ee9f-c93e-4fa4-aeaa-a87ce3b45f2b GET /v1/drugs/75d4ee9f-c93e-4fa4-aeaa-a87ce3b45f2b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69054203",
"date_amm": "2024-05-14",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "SULFATE DE DEXAMFÉTAMINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about dexamfetamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.